Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
New Fortress Energy
NFE
US OptionsDetailed Quotes
AZN250411C45000
- 28.40
- 0.000.00%
15min DelayClose Apr 11 16:00 ET
0.00High0.00Low
0.00Open28.40Pre Close0 Volume5 Open Interest45.00Strike Price0.00Turnover0.00%IV8.60%PremiumApr 11, 2025Expiry Date22.59Intrinsic Value100Multiplier-8DDays to Expiry5.81Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.38Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AstraZeneca Newsroom
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
AstraZeneca's (AZN.US) class 1 innovative drug for breast cancer has been approved in China.
The National Medical Products Administration of China (NMPA) has approved the launch of AstraZeneca's Class 1 Innovative Drug capivasertib.
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
AstraZeneca Unit Faces US Class Action Lawsuit Alleging Misuse of Soliris Patent
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Trump Targets Medicare Price Negotiations in New Executive Order
BNP Paribas Starts Astrazeneca at Outperform Rating, $75 Price Target
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Viking, Structure, Metsera on a Tear as Pfizer Drops Obesity Pill
AstraZeneca Shareholders Approve All AGM Resolutions Amid Wave Of Regulatory Wins
AstraZeneca: All AGM Resolutions Passed
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
AstraZeneca (AZN) Receives a Buy From UBS
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Goldman Sachs Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $196.51
Eli Lilly, Pfizer, Merck, AbbVie Shares After Trump Reiterates Tariff Threats on Drugs
Shares of Drug Stocks Are Trading Lower After President Trump Reportedly Indicated He Would Announce Tariffs on Pharmaceuticals.
UK Regulator Approves Expanded Use of AstraZeneca's Targeted Cancer Therapy
UK Approves Indication Extension for AstraZeneca-Daiichi Sankyo's Cancer Drug Enhertu
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now